Ovarian Cancer Drugs Global Market Report 2020

Publisher Name :
Date: 09-Dec-2019
No. of pages: 200

Ovarian Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global ovarian cancer drugs market.

Reasons to Purchase

- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.

- Create regional and country strategies on the basis of local data and analysis.

- Identify growth segments for investment.

- Outperform competitors using forecast data and the drivers and trends shaping the market.

- Understand customers based on the latest market research findings.

- Benchmark performance against key competitors.

- Utilize the relationships between key data sets for superior strategizing.

- Suitable for supporting your internal and external presentations with reliable high quality data and analysis

- Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the ovarian cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Ovarian Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

- The Market Characteristics section of the report defines and explains the market.

- The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

- Market Segmentations break down market into sub markets.

- The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

- Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

- The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Tumor Type: Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumor, Germ Cell Tumor, Sex Cord-Stromal Tumor 2) By Distribution Channel: Hospital Pharmacies, Drug Stores, Others 3) By Drug Type: Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, VEGF/VEGFR inhibitors, PARP inhibitors, Antineoplastics, Others

Companies Mentioned: AstraZeneca, Roche, Tesaro, Clovis Oncology, Boehringer Ingelheim

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Ovarian Cancer Drugs Global Market Report 2020

Table of Contents

1. Executive Summary
2. Ovarian Cancer Drugs Market Characteristics
3. Ovarian Cancer Drugs Market Size And Growth
3.1. Global Ovarian Cancer Drugs Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Ovarian Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Ovarian Cancer Drugs Market Segmentation
4.1. Global Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Epithelial Ovarian Cancer
Ovarian Low Malignant Potential Tumor
Germ Cell Tumor
Sex Cord-Stromal Tumor
4.2. Global Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Drug Stores
Others
4.3. Global Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Alkylating Agents
Mitotic Inhibitors
Antirheumatics
Antipsoriatics
VEGF/VEGFR inhibitors
PARP inhibitors
Antineoplastics
Others
5. Ovarian Cancer Drugs Market Regional And Country Analysis
5.1. Global Ovarian Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Ovarian Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Ovarian Cancer Drugs Market
6.1. Asia-Pacific Ovarian Cancer Drugs Market Overview
6.2. Asia-Pacific Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Ovarian Cancer Drugs Market
7.1. China Ovarian Cancer Drugs Market Overview
7.2. China Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.4. China Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Ovarian Cancer Drugs Market
8.1. India Ovarian Cancer Drugs Market Overview
8.2. India Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.4. India Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Ovarian Cancer Drugs Market
9.1. Japan Ovarian Cancer Drugs Market Overview
9.2. Japan Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.4. Japan Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Ovarian Cancer Drugs Market
10.1. Australia Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.3. Australia Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Ovarian Cancer Drugs Market
11.1. Indonesia Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.3. Indonesia Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Ovarian Cancer Drugs Market
12.1. South Korea Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.3. South Korea Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Ovarian Cancer Drugs Market
13.1. Western Europe Ovarian Cancer Drugs Market Overview
13.2. Western Europe Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.4. Western Europe Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Ovarian Cancer Drugs Market
14.1. UK Ovarian Cancer Drugs Market Overview
14.2. UK Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.4. UK Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Ovarian Cancer Drugs Market
15.1. Germany Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.3. Germany Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Ovarian Cancer Drugs Market
16.5. France Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.6. France Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.7. France Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Ovarian Cancer Drugs Market
17.1. Eastern Europe Ovarian Cancer Drugs Market Overview
17.2. Eastern Europe Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.4. Eastern Europe Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Ovarian Cancer Drugs Market
18.1. Russia Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.3. Russia Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Ovarian Cancer Drugs Market
19.1. North America Ovarian Cancer Drugs Market Overview
19.2. North America Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.4. North America Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Ovarian Cancer Drugs Market
20.1. USA Ovarian Cancer Drugs Market Overview
20.2. USA Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.4. USA Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Ovarian Cancer Drugs Market
21.1. South America Ovarian Cancer Drugs Market Overview
21.2. South America Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.4. South America Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Ovarian Cancer Drugs Market
22.1. Brazil Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.3. Brazil Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Ovarian Cancer Drugs Market
23.1. Middle East Ovarian Cancer Drugs Market Overview
23.2. Middle East Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.4. Middle East Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Ovarian Cancer Drugs Market
24.1. Africa Ovarian Cancer Drugs Market Overview
24.2. Africa Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.4. Africa Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Ovarian Cancer Drugs Market Competitive Landscape And Company Profiles
25.1. Ovarian Cancer Drugs Market Competitive Landscape
25.2. Ovarian Cancer Drugs Market Company Profiles
25.2.1. AstraZeneca
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Roche
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Tesaro
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Clovis Oncology
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Boehringer Ingelheim
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Ovarian Cancer Drugs Market
27. Ovarian Cancer Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Ovarian Cancer Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer



List of Tables

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Ovarian Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Global Ovarian Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: Asia-Pacific, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: China, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: China, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: China, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: India, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: India, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: India, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Japan, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Japan, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: Japan, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: Australia, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: Australia, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Australia, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: Indonesia, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: Indonesia, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: Indonesia, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: South Korea, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: South Korea, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: South Korea, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: Western Europe, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Western Europe, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Western Europe, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: UK, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: UK, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: UK, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: Germany, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: Germany, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: Germany, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: France, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: France, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: France, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Eastern Europe, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Eastern Europe, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Eastern Europe, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Russia, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Russia, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 46: Russia, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 47: North America, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 48: North America, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 49: North America, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 50: USA, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 51: USA, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 52: USA, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 53: South America, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 54: South America, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 55: South America, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 56: Brazil, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 57: Brazil, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 58: Brazil, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 59: Middle East, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 60: Middle East, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 61: Middle East, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 62: Africa, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 63: Africa, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 64: Africa, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 65: AstraZeneca Financial Performance
Table 66: Roche Financial Performance
Table 67: Tesaro Financial Performance
Table 68: Clovis Oncology Financial Performance
Table 69: Boehringer Ingelheim Financial Performance


List of Figures

Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Ovarian Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Global Ovarian Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: Asia-Pacific, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: China, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: China, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: China, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: India, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: India, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: India, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Japan, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Japan, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: Japan, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: Australia, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: Australia, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Australia, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: Indonesia, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: Indonesia, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: Indonesia, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: South Korea, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: South Korea, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: South Korea, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: Western Europe, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Western Europe, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Western Europe, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: UK, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: UK, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: UK, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: Germany, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: Germany, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: Germany, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: France, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: France, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: France, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Eastern Europe, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Eastern Europe, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Eastern Europe, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Russia, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Russia, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 46: Russia, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 47: North America, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 48: North America, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 49: North America, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 50: USA, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 51: USA, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 52: USA, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 53: South America, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 54: South America, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 55: South America, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 56: Brazil, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 57: Brazil, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 58: Brazil, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 59: Middle East, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 60: Middle East, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 61: Middle East, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 62: Africa, Ovarian Cancer Drugs Market, Segmentation By Tumor Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 63: Africa, Ovarian Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 64: Africa, Ovarian Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 65: AstraZeneca Financial Performance
Figure 66: Roche Financial Performance
Figure 67: Tesaro Financial Performance
Figure 68: Clovis Oncology Financial Performance
Figure 69: Boehringer Ingelheim Financial Performance
  • Global Amifostine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 13-Jan-2020        Price: US 3480 Onwards        Pages: 106
    Summary Market Overview The global Amifostine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 56 million by 2025, from USD 52 million in 2019. The Amifostine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis......
  • Global Methotrexate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 10-Jan-2020        Price: US 3480 Onwards        Pages: 101
    Summary Market Overview The global Methotrexate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 557.6 million by 2025, from USD 503.5 million in 2019. The Methotrexate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sale......
  • Global Paclitaxel Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 106
    Summary Market Overview The global Paclitaxel market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.3% in the forecast period of 2020 to 2025 and will expected to reach USD 152 million by 2025, from USD 110.4 million in 2019. The Paclitaxel market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales anal......
  • Global Cytotoxic Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 104
    Summary Market Overview The global Cytotoxic Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15150 million by 2025, from USD 14580 million in 2019. The Cytotoxic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, ......
  • Global Hydroxycarbamide Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 122
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • Global Docetaxel Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 95
    Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein. The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017. Do......
  • Global Cancer Treatment Drugs Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 130
    Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%. Cancer treatment drugs are widely used for blood cancer, breast......
  • Global Lentinan Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 100
    Summary Market Overview The global Lentinan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 11 million by 2025, from USD 10 million in 2019. The Lentinan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, im......
  • Global Capecitabine Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs